136 related articles for article (PubMed ID: 869513)
1. Relationship between chemical structure and adjuvant activity of some synthetic analogues of N-acetyl-muramyl-L-alanyl-D-isoglutamine (MDP).
Audibert F; Chedid L; Lefrancier P; Choay J; Lederer E
Ann Immunol (Paris); 1977; 128C(3):653-61. PubMed ID: 869513
[TBL] [Abstract][Full Text] [Related]
2. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
Heymer B; Finger H; Wirsing CH
Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
[TBL] [Abstract][Full Text] [Related]
3. Influence of a synthetic adjuvant (MDP) on qualitative and quantitative changes of serum globulins.
Leclerc C; Audibert F; Chedid L
Immunology; 1978 Dec; 35(6):963-70. PubMed ID: 738768
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of the in vivo dinitrophenyl antibody response to the DNP conjugate of L-glutamic acid60-L-alanine30-L-Tyrosine10 (GAT) polymer by a synthetic adjuvant, muramyl dipeptide (MDP): target cells for adjuvant activity and isotypic pattern of MDP-stimulated response.
Lowy I; Theze J; Chedid L
J Immunol; 1980 Jan; 124(1):100-4. PubMed ID: 6965289
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of carrier-specific helper T cell function by the synthetic adjuvant, N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP).
Sugimoto M; Germain RN; Chedid L; Benacerraf B
J Immunol; 1978 Mar; 120(3):980-2. PubMed ID: 344799
[TBL] [Abstract][Full Text] [Related]
6. Immunoadjuvant activities of synthetic N-acetyl-muramyl-peptides or -amino acids.
Kotani S; Watanabe Y; Kinoshita F; Shimono T; Morisaki I
Biken J; 1975 Jun; 18(2):105-11. PubMed ID: 1180867
[TBL] [Abstract][Full Text] [Related]
7. The comparative selectivity of adjuvants for humoral and cell-mediated immunity. I. Effect on the antibody response to bovine serum albumin and sheep red blood cells of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin.
Bomford R
Clin Exp Immunol; 1980 Feb; 39(2):426-34. PubMed ID: 6248282
[TBL] [Abstract][Full Text] [Related]
8. Opposite effects of the synthetic adjuvant N-acetyl-muramyl-L-alanyl-D-isoglutamine on the immune response in mice depending on experimental conditions.
Souvannavong V; Adam A
Eur J Immunol; 1980 Aug; 10(8):654-6. PubMed ID: 6995138
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant activity of some nonpyrogenic hydrophobic analogues of muramyl dipeptide in enhancing the primary humoral and cell mediated immune responses in guinea pig model.
Saxena RP; Puri A; Saxena KC; Shukla R; Haq W; Rizvi SY; Kundu B; Mathur KB
Indian J Exp Biol; 1991 Feb; 29(2):111-5. PubMed ID: 1869292
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of serum antibody production in mice by oral administration of lipophilic derivatives of muramyl peptides and bacterial lipopolysaccharides with bovine serum albumin.
Ogawa T; Kotani S; Shimauchi H
Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):117-25. PubMed ID: 3713372
[TBL] [Abstract][Full Text] [Related]
11. Genetic influences on the adjuvanticity of muramyl dipeptide in vivo.
Staruch MJ; Wood DD
J Immunol; 1982 Jan; 128(1):155-60. PubMed ID: 6976368
[TBL] [Abstract][Full Text] [Related]
12. Influence of indomethacin on various immunopharmacological effects of muramyl dipeptide (MDP).
Parant M; Riveau G; Chedid L
Agents Actions Suppl; 1980; 7():33-40. PubMed ID: 6941684
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of serum antibody production in mice by oral administration of lipophilic derivatives of muramylpeptides and bacterial lipopolysaccharides with bovine serum albumin.
Ogawa T; Kotani S; Shimauchi H
Methods Find Exp Clin Pharmacol; 1986 Jan; 8(1):19-26. PubMed ID: 3702542
[TBL] [Abstract][Full Text] [Related]
14. Immunoadjuvant activities of synthetic 6-O-acyl-N-acetylmuramyl-L-alanyl-D-isoglutamine with special reference to the effect of its administration with liposomes.
Kotani S; Kinoshita F; Morisaki I; Shimono T; Okunaga T; Takada H; Tsujimoto M; Watanabe Y; Kato K; Shiba T; Kusumoto S; Okada S
Biken J; 1977 Dec; 20(3-4):95-103. PubMed ID: 614856
[TBL] [Abstract][Full Text] [Related]
15. Macrophage activation by mycobacterial water soluble compounds and synthetic muramyl dipeptide.
Wahl SM; Wahl LM; McCarthy JB; Chedid L; Mergenhagen SE
J Immunol; 1979 Jun; 122(6):2226-31. PubMed ID: 221582
[TBL] [Abstract][Full Text] [Related]
16. The effect of replacement of L-alanine residue by glycine, L-serine or D-alanine in an N-acetylmuramyl-L-alanyl-D-isoglutamine on immunoadjuvancies of molecules.
Kotani S; Watanabe Y; Kinoshita F; Morisaki I; Kato K
Biken J; 1977 Jun; 20(2):39-45. PubMed ID: 588232
[TBL] [Abstract][Full Text] [Related]
17. Further study on relationship of anti-tuberculous protection to lung granulomata produced by intravenous injections of synthetic 6-0-mycoloyl-N-acetyl-muramyl-L-alanyl-D-isoglutamine with or without specific antigens.
Yamamoto K; Kato K; Kakinuma M; Okuyama H; Azuma I
Immunology; 1982 Jun; 46(2):473-9. PubMed ID: 7044961
[TBL] [Abstract][Full Text] [Related]
18. Peptidoglycan adjuvants: minimal structure required for activity.
Adam A; Ellouz F; Ciorbaru R; Petit JF; Lederer E
Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(2-4):341-8. PubMed ID: 126566
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of structurally related peptidoglycan monomer and muramyl dipeptide on humoral IgG immune response to ovalbumin in mouse.
Habjanec L; Halassy B; Tomasić J
Int Immunopharmacol; 2010 Jul; 10(7):751-9. PubMed ID: 20403461
[TBL] [Abstract][Full Text] [Related]
20. Acute and chronic polyarthritis induced by an aqueous form of 6-O-acyl and N-acyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in euthymic rats and athymic nude rats.
Kohashi O; Kohashi Y; Shigematsu N; Ozawa A; Kotani S
Lab Invest; 1986 Sep; 55(3):337-46. PubMed ID: 3489128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
